SCHEMBL3327772

SCHEMBL3327772

CCN1CCCC1CNc1nc(-c2ccncc2)cc2cnccc12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKCD Q05655 11/20 0.54
PRKCH P24723 10/20 0.54
PRKCE Q02156 9/20 0.54
PRKCQ Q04759 8/20 0.54
PRKCA P17252 9/20 0.52
PRKCB P05771 5/20 0.52
PRKD1 Q15139 3/20 0.52
ROCK2 O75116 2/20 0.52
ROCK1 Q13464 2/20 0.52
PKN1 Q16512 2/20 0.52
PKN2 Q16513 2/20 0.52
CYP1A2 P05177 1/20 0.52
ACHE P22303 1/20 0.47
DRD2 P14416 1/20 0.44
LATS1 O95835 1/20 0.43
LATS2 Q9NRM7 1/20 0.43
KDM4E B2RXH2 2/20 0.42
ALDH1A1 P00352 2/20 0.42
HSD17B10 Q99714 2/20 0.42
LMNA P02545 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10134675 0.79 DRD2 (0.47) ACHEDRD2LATS1LATS2KDM4E
SCHEMBL4774016 0.77 ACP1 (0.52) ACHEDRD2KDM4EALDH1A1HSD17B10
Hydrochloric Acid SCHEMBL4769537 0.77 ACP1 (0.51) ACHEDRD2KDM4EALDH1A1HSD17B10
SCHEMBL22201647 0.76 HPGD (0.54) ACHEKDM4EALDH1A1HSD17B10LMNA
SCHEMBL3327386 0.74 PRKCD (0.56) PRKCDPRKCHPRKCEPRKCQPRKCA
SCHEMBL3326355 0.74 PRKCD (0.58) PRKCDPRKCHPRKCEPRKCQPRKCA
SCHEMBL3325544 0.74 PRKCD (0.55) PRKCDPRKCHPRKCEPRKCQPRKCA
SCHEMBL3325550 0.74 PRKCD (0.55) PRKCDPRKCHPRKCEPRKCQPRKCA
SCHEMBL10131789 0.72 CSNK2A1 (0.59)
SCHEMBL3325609 0.72 PRKCD (0.65) PRKCDPRKCHPRKCEPRKCQPRKCA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100130469-A1 2, 6-NAPHTHRIDINE DERIVATIVES VAN EIS MAURICE 2010-05-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100130469-A1 2, 6-NAPHTHRIDINE DERIVATIVES PKN1, PKN2, CDK9 PRKCD 63/4885PRKCH 22/4885PRKCE 18/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.